Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Exact Sciences Corporation - Common Stock
(NQ:
EXAS
)
43.45
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 1, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Exact Sciences Corporation - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Exact Sciences Stock Plunges On Q1 Earnings: What You Need To Know
May 08, 2024
Exact Sciences said first-quarter revenue increased 6% year-over-year to $638 million, which beat the consensus estimate of $627.355 million, according to Benzinga Pro. The company reported a quarterly...
Via
Benzinga
Exact Sciences Stock, A Cathie Wood Darling, Tumbles On Wide Quarterly Losses
May 08, 2024
The company reported better-than-expected sales, but losses widened and missed forecasts.
Via
Investor's Business Daily
12 Health Care Stocks Moving In Wednesday's After-Market Session
May 08, 2024
Via
Benzinga
Exact Sciences Announces First-Quarter 2024 Results
May 08, 2024
From
Exact Sciences Corp.
Via
Business Wire
Stocks Falter As Fed Signals Need For Higher-For-Longer Rates; Uber Crashes, Energy Sector Loses Ground: What's Driving Wednesday's Market?
May 08, 2024
Wednesday witnessed a tempering of the bullish sentiment that had buoyed Wall Street in recent sessions, with major indices showing slight declines around midday trading in New York.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Wall Street Poised For Muted Open On Mixed Earnings, With More Fed Speeches In Store: Analyst Sees S&P 500 Crossing Late-March High
May 08, 2024
U.S. stocks are on track for a mixed start on Wednesday as the market digests mixed earnings reports and looks ahead to more speeches by Federal Reserve officials.
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Exact Sciences Demonstrates Continued Scientific Advancement in Colorectal Cancer Screening with Multiple Data Presentations at DDW® 2024
May 07, 2024
From
Exact Sciences Corp.
Via
Business Wire
(EXAS) - Analyzing Exact Sciences's Short Interest
April 01, 2024
Via
Benzinga
2 Beaten-Down Cathie Wood Stocks With Massive Potential
March 11, 2024
They won't lag the market forever.
Via
The Motley Fool
Will Earnings Cheer Continue This Week? All Eyes On Disney, Palantir, Robinhood While Reddit Gears Up For Debut Quarterly Report
May 06, 2024
According to FactSet, a financial data analytics firm, 80% of S&P 500 companies have reported earnings so far.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Exact Sciences to Participate in May Investor Conference
May 01, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Names Aaron Bloomer as New Chief Financial Officer
April 15, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Announces Debt Exchange Transaction and Private Placement of Convertible Senior Notes
April 11, 2024
From
Exact Sciences Corp.
Via
Business Wire
10 Health Care Stocks With Whale Alerts In Today's Session
April 09, 2024
Via
Benzinga
Exact Sciences to Present Late-Breaking Data from ASCEND-2 Study Validating Its Investigational Multi-Cancer Early Detection Test at AACR Annual Meeting 2024
April 08, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences Schedules First Quarter 2024 Earnings Call
April 08, 2024
From
Exact Sciences Corp.
Via
Business Wire
The 3 Best Cathie Wood Stocks to Buy in April 2024
April 05, 2024
Cathie Wood doesn't have a great overall record, but she sometimes makes great picks. Here are the three best Cathie Wood stocks to buy now.
Via
InvestorPlace
1 Beaten-Down Cathie Wood Stock to Buy and Hold
April 04, 2024
This company is innovating where it matters most, which could prove highly lucrative down the road.
Via
The Motley Fool
Exact Sciences to Provide Mayo Clinic Patients with Individualized Cancer Tumor Information to Inform Treatment
April 04, 2024
From
Exact Sciences Corp.
Via
Business Wire
Exact Sciences, A Cathie Wood Stock, Surges As Rival Colon Cancer Test Pales
April 02, 2024
The companies are working to detect colon cancer and precancerous markers in blood and/or stool.
Via
Investor's Business Daily
ChampionX, Montrose Environmental Group And Other Big Stocks Moving Higher On Tuesday
April 02, 2024
U.S. stocks were lower, with the Dow Jones falling around 400 points on Tuesday.
Via
Benzinga
Topics
Stocks
Exposures
US Equities
10 Health Care Stocks Whale Activity In Today's Session
March 29, 2024
Via
Benzinga
REX American Resources Reports Upbeat Earnings, Joins Avalo Therapeutics, RH And Other Big Stocks Moving Higher On Thursday
March 28, 2024
U.S. stocks were slightly higher, with the S&P 500 gaining around 0.1% on Thursday. Shares of REX American Resources Corporation (NYSE: REX) rose sharply during Thursday’s session following upbeat...
Via
Benzinga
Exact Sciences Advances Development of Non-Endoscopic Oncoguard® Esophagus Test to Screen for Esophageal Cancer and Pre-Cancer
March 28, 2024
From
Exact Sciences Corp.
Via
Business Wire
3 Biotech Stocks to Buy on the Dip: March 2024
March 27, 2024
Some of the best opportunities can be found in dips in some of the top biotech stocks to buy. In fact, here are three.
Via
InvestorPlace
Exact Sciences Named 2024 Gallup Exceptional Workplace Award Winner
March 27, 2024
From
Exact Sciences Corp.
Via
Business Wire
3 Growth Stocks to Buy at 52-Week Lows in March
March 26, 2024
Wager on these growth stocks to buy at 52-week lows offering robust investment potential ahead for savvy investors.
Via
InvestorPlace
The New England Journal of Medicine Publishes Cologuard Plus™ Test Results from Pivotal BLUE-C Study
March 13, 2024
From
Exact Sciences Corp.
Via
Business Wire
Cathie Wood Darling Exact Sciences Could Pop After Its Next-Gen Product Outperforms
March 13, 2024
Exact Sciences is hoping to launch an next-generation version of Cologuard in 2025.
Via
Investor's Business Daily
5 Biotechnology Stocks To Buy For A Stable Portfolio In 2024
March 09, 2024
Things have been looking better for the biotech industry in 2024 after a decent performance in 2023. Here is a look at some biotech stocks that may provide stability to one's portfolio throughout the...
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
...
16
17
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.